Text Size

Sensitization in Osteoarthritic Knees

This study has been completed.
Sponsor:
Collaborator:
Aalborg University
Information provided by (Responsible Party):
Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier:
NCT00379184
First received: September 19, 2006
Last updated: May 1, 2013
Last verified: May 2013
History of Changes
  Purpose

Musculoskeletal pains represent a major part of pain complaints in patients. Moreover, the treatment of musculoskeletal pain conditions by currently available drugs is not optimal (Curatolo and Bogduk 2001). Thus, deep pain is a diagnostic and therapeutic problem, and further insights into the peripheral and central neurophysiologic mechanisms are necessary to improve diagnosis and therapy and to implement a mechanism-based approach. Peripheral sensitization and central hyper excitability are, most likely the important factors for chronic musculoskeletal pain and in particular osteoarthritis (OA).

The focus of this project is to study the involvement of peripheral and central sensitization underlying deep tissue hyperalgesia and referred pain in male and female OA patients.

Adequate quantitative sensory testing assessment techniques for measuring hyper excitability are needed to investigate, in more detail the mechanisms involved in generating the sensitization in OA patients.


Condition
Arthritis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Quantitative Assessment of Central Sensitization in Osteoarthritis Patients

Resource links provided by NLM:

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources

Further study details as provided by Northern Orthopaedic Division, Denmark:

Enrollment: 72
Study Start Date: September 2006
Study Completion Date: June 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
A
Osteoarthritis patients scheduled for Total Knee Arthroplasty.
B
Osteoarthritis patients not scheduled for Total Knee Arthroplasty.
C
Healthy volunteers

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients with knee OA

Criteria

Inclusion Criteria:

  • Osteoarthritis in the knee

Exclusion Criteria:

  • No other painful conditions
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00379184

Locations
Denmark
Northern Orthopaedic Division, Clinic Farsoe, Aalborg University Hospital and Aalborg University
Farsoe, Northern Jutland, Denmark
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
Aalborg University
Investigators
Principal Investigator: Mogens B Laursen, MD, PhD Northern Orthopaedic Division
  More Information

No publications provided

Responsible Party: Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier: NCT00379184     History of Changes
Other Study ID Numbers: ON-04-014-MBL
Study First Received: September 19, 2006
Last Updated: May 1, 2013
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics
Denmark: Danish Dataprotection Agency

Keywords provided by Northern Orthopaedic Division, Denmark:
arthritis

Additional relevant MeSH terms:
Arthritis
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on May 23, 2013